Article
Biochemical and biophysical properties of a rare TTRA81V mutation causing mild transthyretin amyloid cardiomyopathy.
ESC heart failure - 1 Feb 2024
Sha Qiuyan, Zhang Yanli, Wang Mengdie, Sun Jialu, Zhang Yunlong, Zhang Xinxin, Wang Ning, Liu Yu, Liu Ying
Abstract excerpt
AIMS: We conducted a presentation on an 84-year-old male patient who has been diagnosed with TTRA81V (p. TTRA101V) hereditary transthyretin cardiac amyloidosis (hATTR-CM). In order to establish its pathogenicity, we extensively investigated the biochemical and biophysical properties of the condition. METHODS AND RESULTS: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly acknowledged progressive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
